InterMune acquires Actimmune rights

ITMN acquired exclusive Canadian rights from Genentech (DNA) to Actimmune interferon gamma to treat chronic granulomatous disease (CGD), osteopetrosis, idiopathic pulmonary fibrosis and infectious dis...